This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator.
Specific Aim : To characterize the safety and tolerability of LIPO-5 (total dose of 2500 mcg) when given alone and HIV.
Showing the most recent 10 out of 515 publications